A second-generation 15-PGDH inhibitor promotes bone marrow transplant recovery independently of age, transplant dose and granulocyte colony-stimulating factor support

Hematopoietic stem cell transplantation following myeloablative chemotherapy is a curative treatment for many hematopoietic malignancies. However, profound granulocytopenia during the interval between transplantation and marrow recovery exposes recipients to risks of fatal infection, a significant s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Haematologica
Autors principals: Desai, Amar, Zhang, Yongyou, Park, Youngsoo, Dawson, Dawn M., Larusch, Gretchen A., Kasturi, Lakshmi, Wald, David, Ready, Joseph M., Gerson, Stanton L., Markowitz, Sanford D.
Format: Artigo
Idioma:Inglês
Publicat: Ferrata Storti Foundation 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6058768/
https://ncbi.nlm.nih.gov/pubmed/29472361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2017.178376
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars